These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 32654539)
1. Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant Data. Mahmoodi BK; Tragante V; Kleber ME; Holmes MV; Schmidt AF; McCubrey RO; Howe LJ; Direk K; Allayee H; Baranova EV; Braund PS; Delgado GE; Eriksson N; Gijsberts CM; Gong Y; Hartiala J; Heydarpour M; Pasterkamp G; Kotti S; Kuukasjärvi P; Lenzini PA; Levin D; Lyytikäinen LP; Muehlschlegel JD; Nelson CP; Nikus K; Pilbrow AP; Wilson Tang WH; van der Laan SW; van Setten J; Vilmundarson RO; Deanfield J; Deloukas P; Dudbridge F; James S; Mordi IR; Teren A; Bergmeijer TO; Body SC; Bots M; Burkhardt R; Cooper-DeHoff RM; Cresci S; Danchin N; Doughty RN; Grobbee DE; Hagström E; Hazen SL; Held C; Hoefer IE; Hovingh GK; Johnson JA; Kaczor MP; Kähönen M; Klungel OH; Laurikka JO; Lehtimäki T; Maitland-van der Zee AH; McPherson R; Palmer CN; Kraaijeveld AO; Pepine CJ; Sanak M; Sattar N; Scholz M; Simon T; Spertus JA; Stewart AFR; Szczeklik W; Thiery J; Visseren FLJ; Waltenberger J; Richards AM; Lang CC; Cameron VA; Åkerblom A; Pare G; März W; Samani NJ; Hingorani AD; Ten Berg JM; Wallentin L; Asselbergs FW; Patel RS Circulation; 2020 Aug; 142(6):546-555. PubMed ID: 32654539 [TBL] [Abstract][Full Text] [Related]
2. Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials. Mahmoodi BK; Eriksson N; Ross S; Claassens DMF; Asselbergs FW; Meijer K; Siegbahn A; James S; Pare G; Wallentin L; Ten Berg JM J Am Heart Assoc; 2021 Sep; 10(17):e021115. PubMed ID: 34459239 [TBL] [Abstract][Full Text] [Related]
3. Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events. Patel RS; Schmidt AF; Tragante V; McCubrey RO; Holmes MV; Howe LJ; Direk K; Åkerblom A; Leander K; Virani SS; Kaminski KA; Muehlschlegel JD; Dubé MP; Allayee H; Almgren P; Alver M; Baranova EV; Behlouli H; Boeckx B; Braund PS; Breitling LP; Delgado G; Duarte NE; Dufresne L; Eriksson N; Foco L; Gijsberts CM; Gong Y; Hartiala J; Heydarpour M; Hubacek JA; Kleber M; Kofink D; Kuukasjärvi P; Lee VV; Leiherer A; Lenzini PA; Levin D; Lyytikäinen LP; Martinelli N; Mons U; Nelson CP; Nikus K; Pilbrow AP; Ploski R; Sun YV; Tanck MWT; Tang WHW; Trompet S; van der Laan SW; van Setten J; Vilmundarson RO; Viviani Anselmi C; Vlachopoulou E; Boerwinkle E; Briguori C; Carlquist JF; Carruthers KF; Casu G; Deanfield J; Deloukas P; Dudbridge F; Fitzpatrick N; Gigante B; James S; Lokki ML; Lotufo PA; Marziliano N; Mordi IR; Muhlestein JB; Newton Cheh C; Pitha J; Saely CH; Samman-Tahhan A; Sandesara PB; Teren A; Timmis A; Van de Werf F; Wauters E; Wilde AAM; Ford I; Stott DJ; Algra A; Andreassi MG; Ardissino D; Arsenault BJ; Ballantyne CM; Bergmeijer TO; Bezzina CR; Body SC; Bogaty P; de Borst GJ; Brenner H; Burkhardt R; Carpeggiani C; Condorelli G; Cooper-DeHoff RM; Cresci S; de Faire U; Doughty RN; Drexel H; Engert JC; Fox KAA; Girelli D; Hagström E; Hazen SL; Held C; Hemingway H; Hoefer IE; Hovingh GK; Johnson JA; de Jong PA; Jukema JW; Kaczor MP; Kähönen M; Kettner J; Kiliszek M; Klungel OH; Lagerqvist B; Lambrechts D; Laurikka JO; Lehtimäki T; Lindholm D; Mahmoodi BK; Maitland-van der Zee AH; McPherson R; Melander O; Metspalu A; Pepinski W; Olivieri O; Opolski G; Palmer CN; Pasterkamp G; Pepine CJ; Pereira AC; Pilote L; Quyyumi AA; Richards AM; Sanak M; Scholz M; Siegbahn A; Sinisalo J; Smith JG; Spertus JA; Stewart AFR; Szczeklik W; Szpakowicz A; Ten Berg JM; Thanassoulis G; Thiery J; van der Graaf Y; Visseren FLJ; Waltenberger J; ; Van der Harst P; Tardif JC; Sattar N; Lang CC; Pare G; Brophy JM; Anderson JL; März W; Wallentin L; Cameron VA; Horne BD; Samani NJ; Hingorani AD; Asselbergs FW Circ Genom Precis Med; 2019 Apr; 12(4):e002471. PubMed ID: 30897348 [TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
5. Role of factor V Leiden mutation in patients with angiographically demonstrated coronary artery disease. Dunn ST; Roberts CR; Schechter E; Moore WE; Lee ET; Eichner JE Thromb Res; 1998 Jul; 91(2):91-9. PubMed ID: 9722025 [TBL] [Abstract][Full Text] [Related]
6. Association of Sickle Cell Trait With Incidence of Coronary Heart Disease Among African American Individuals. Hyacinth HI; Franceschini N; Seals SR; Irvin MR; Chaudhary N; Naik RP; Alonso A; Carty CL; Burke GL; Zakai NA; Winkler CA; David VA; Kopp JB; Judd SE; Adams RJ; Gee BE; Longstreth WT; Egede L; Lackland DT; Greenberg CS; Taylor H; Manson JE; Key NS; Derebail VK; Kshirsagar AV; Folsom AR; Konety SH; Howard V; Allison M; Wilson JG; Correa A; Zhi D; Arnett DK; Howard G; Reiner AP; Cushman M; Safford MM JAMA Netw Open; 2021 Jan; 4(1):e2030435. PubMed ID: 33399855 [TBL] [Abstract][Full Text] [Related]
7. Factor V Leiden and prothrombin G20210A mutations and the risk of atherothrombotic events in systemic lupus erythematosus. Pullmann R; Skerenová M; Lukác J; Hybenová J; Melus V; Kubisz P; Rovenský J; Pullmann R Clin Appl Thromb Hemost; 2004 Jul; 10(3):233-8. PubMed ID: 15247980 [TBL] [Abstract][Full Text] [Related]
8. Exercise-based cardiac rehabilitation for coronary heart disease. Anderson L; Thompson DR; Oldridge N; Zwisler AD; Rees K; Martin N; Taylor RS Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD001800. PubMed ID: 26730878 [TBL] [Abstract][Full Text] [Related]
9. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702 [TBL] [Abstract][Full Text] [Related]
10. Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type. Sode BF; Allin KH; Dahl M; Gyntelberg F; Nordestgaard BG CMAJ; 2013 Mar; 185(5):E229-37. PubMed ID: 23382263 [TBL] [Abstract][Full Text] [Related]
11. Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis. Schillemans T; Tragante V; Maitusong B; Gigante B; Cresci S; Laguzzi F; Vikström M; Richards M; Pilbrow A; Cameron V; Foco L; Doughty RN; Kuukasjärvi P; Allayee H; Hartiala JA; Tang WHW; Lyytikäinen LP; Nikus K; Laurikka JO; Srinivasan S; Mordi IR; Trompet S; Kraaijeveld A; van Setten J; Gijsberts CM; Maitland-van der Zee AH; Saely CH; Gong Y; Johnson JA; Cooper-DeHoff RM; Pepine CJ; Casu G; Leiherer A; Drexel H; Horne BD; van der Laan SW; Marziliano N; Hazen SL; Sinisalo J; Kähönen M; Lehtimäki T; Lang CC; Burkhardt R; Scholz M; Jukema JW; Eriksson N; Åkerblom A; James S; Held C; Hagström E; Spertus JA; Algra A; de Faire U; Åkesson A; Asselbergs FW; Patel RS; Leander K Front Physiol; 2022; 13():909870. PubMed ID: 35812313 [No Abstract] [Full Text] [Related]
12. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms. Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978 [TBL] [Abstract][Full Text] [Related]
13. Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease. Herrington DM; Vittinghoff E; Howard TD; Major DA; Owen J; Reboussin DM; Bowden D; Bittner V; Simon JA; Grady D; Hulley SB Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):1012-7. PubMed ID: 12067913 [TBL] [Abstract][Full Text] [Related]
14. Predictive Accuracy of a Polygenic Risk Score Compared With a Clinical Risk Score for Incident Coronary Heart Disease. Mosley JD; Gupta DK; Tan J; Yao J; Wells QS; Shaffer CM; Kundu S; Robinson-Cohen C; Psaty BM; Rich SS; Post WS; Guo X; Rotter JI; Roden DM; Gerszten RE; Wang TJ JAMA; 2020 Feb; 323(7):627-635. PubMed ID: 32068817 [TBL] [Abstract][Full Text] [Related]
15. Psychological interventions for coronary heart disease. Richards SH; Anderson L; Jenkinson CE; Whalley B; Rees K; Davies P; Bennett P; Liu Z; West R; Thompson DR; Taylor RS Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002902. PubMed ID: 28452408 [TBL] [Abstract][Full Text] [Related]
16. Subsequent Event Risk in Individuals With Established Coronary Heart Disease. Patel RS; Tragante V; Schmidt AF; McCubrey RO; Holmes MV; Howe LJ; Direk K; Åkerblom A; Leander K; Virani SS; Kaminski KA; Muehlschlegel JD; Allayee H; Almgren P; Alver M; Baranova EV; Behloui H; Boeckx B; Braund PS; Breitling LP; Delgado G; Duarte NE; Dubé MP; Dufresne L; Eriksson N; Foco L; Scholz M; Gijsberts CM; Glinge C; Gong Y; Hartiala J; Heydarpour M; Hubacek JA; Kleber M; Kofink D; Kotti S; Kuukasjärvi P; Lee VV; Leiherer A; Lenzini PA; Levin D; Lyytikäinen LP; Martinelli N; Mons U; Nelson CP; Nikus K; Pilbrow AP; Ploski R; Sun YV; Tanck MWT; Tang WHW; Trompet S; van der Laan SW; Van Setten J; Vilmundarson RO; Viviani Anselmi C; Vlachopoulou E; Al Ali L; Boerwinkle E; Briguori C; Carlquist JF; Carruthers KF; Casu G; Deanfield J; Deloukas P; Dudbridge F; Engstrøm T; Fitzpatrick N; Fox K; Gigante B; James S; Lokki ML; Lotufo PA; Marziliano N; Mordi IR; Muhlestein JB; Newton-Cheh C; Pitha J; Saely CH; Samman-Tahhan A; Sandesara PB; Teren A; Timmis A; Van de Werf F; Wauters E; Wilde AAM; Ford I; Stott DJ; Algra A; Andreassi MG; Ardissino D; Arsenault BJ; Ballantyne CM; Bergmeijer TO; Bezzina CR; Body SC; Boersma EH; Bogaty P; Bots ML; Brenner H; Brugts JJ; Burkhardt R; Carpeggiani C; Condorelli G; Cooper-DeHoff RM; Cresci S; Danchin N; de Faire U; Doughty RN; Drexel H; Engert JC; Fox KAA; Girelli D; Grobbee DE; Hagström E; Hazen SL; Held C; Hemingway H; Hoefer IE; Hovingh GK; Jabbari R; Johnson JA; Jukema JW; Kaczor MP; Kähönen M; Kettner J; Kiliszek M; Klungel OH; Lagerqvist B; Lambrechts D; Laurikka JO; Lehtimäki T; Lindholm D; Mahmoodi BK; Maitland-van der Zee AH; McPherson R; Melander O; Metspalu A; Niemcunowicz-Janica A; Olivieri O; Opolski G; Palmer CN; Pasterkamp G; Pepine CJ; Pereira AC; Pilote L; Quyyumi AA; Richards AM; Sanak M; Siegbahn A; Simon T; Sinisalo J; Smith JG; Spertus JA; Stender S; Stewart AFR; Szczeklik W; Szpakowicz A; Tardif JC; Ten Berg JM; Tfelt-Hansen J; Thanassoulis G; Thiery J; Torp-Pedersen C; van der Graaf Y; Visseren FLJ; Waltenberger J; Weeke PE; Van der Harst P; Lang CC; Sattar N; Cameron VA; Anderson JL; Brophy JM; Pare G; Horne BD; März W; Wallentin L; Samani NJ; Hingorani AD; Asselbergs FW Circ Genom Precis Med; 2019 Apr; 12(4):e002470. PubMed ID: 30896328 [TBL] [Abstract][Full Text] [Related]
17. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. ; Danesh J; Lewington S; Thompson SG; Lowe GD; Collins R; Kostis JB; Wilson AC; Folsom AR; Wu K; Benderly M; Goldbourt U; Willeit J; Kiechl S; Yarnell JW; Sweetnam PM; Elwood PC; Cushman M; Psaty BM; Tracy RP; Tybjaerg-Hansen A; Haverkate F; de Maat MP; Fowkes FG; Lee AJ; Smith FB; Salomaa V; Harald K; Rasi R; Vahtera E; Jousilahti P; Pekkanen J; D'Agostino R; Kannel WB; Wilson PW; Tofler G; Arocha-Piñango CL; Rodriguez-Larralde A; Nagy E; Mijares M; Espinosa R; Rodriquez-Roa E; Ryder E; Diez-Ewald MP; Campos G; Fernandez V; Torres E; Marchioli R; Valagussa F; Rosengren A; Wilhelmsen L; Lappas G; Eriksson H; Cremer P; Nagel D; Curb JD; Rodriguez B; Yano K; Salonen JT; Nyyssönen K; Tuomainen TP; Hedblad B; Lind P; Loewel H; Koenig W; Meade TW; Cooper JA; De Stavola B; Knottenbelt C; Miller GJ; Cooper JA; Bauer KA; Rosenberg RD; Sato S; Kitamura A; Naito Y; Palosuo T; Ducimetiere P; Amouyel P; Arveiler D; Evans AE; Ferrieres J; Juhan-Vague I; Bingham A; Schulte H; Assmann G; Cantin B; Lamarche B; Després JP; Dagenais GR; Tunstall-Pedoe H; Woodward M; Ben-Shlomo Y; Davey Smith G; Palmieri V; Yeh JL; Rudnicka A; Ridker P; Rodeghiero F; Tosetto A; Shepherd J; Ford I; Robertson M; Brunner E; Shipley M; Feskens EJ; Kromhout D; Dickinson A; Ireland B; Juzwishin K; Kaptoge S; Lewington S; Memon A; Sarwar N; Walker M; Wheeler J; White I; Wood A JAMA; 2005 Oct; 294(14):1799-809. PubMed ID: 16219884 [TBL] [Abstract][Full Text] [Related]
18. Factor V Leiden and its relation to left ventricular thrombus in acute myocardial infarction. Celik S; Ovali E; Baykan M; Uçar F; Erdöl C; Durmuş I; Kaplan S Acta Cardiol; 2001 Feb; 56(1):1-6. PubMed ID: 11315119 [TBL] [Abstract][Full Text] [Related]
19. Smoking cessation for secondary prevention of cardiovascular disease. Wu AD; Lindson N; Hartmann-Boyce J; Wahedi A; Hajizadeh A; Theodoulou A; Thomas ET; Lee C; Aveyard P Cochrane Database Syst Rev; 2022 Aug; 8(8):CD014936. PubMed ID: 35938889 [TBL] [Abstract][Full Text] [Related]
20. Genetic variants at chromosome 9p21 and risk of first versus subsequent coronary heart disease events: a systematic review and meta-analysis. Patel RS; Asselbergs FW; Quyyumi AA; Palmer TM; Finan CI; Tragante V; Deanfield J; Hemingway H; Hingorani AD; Holmes MV J Am Coll Cardiol; 2014 Jun; 63(21):2234-45. PubMed ID: 24607648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]